Up to three million women in sub-Saharan African and South Asia could soon benefit from a simplified, more accessible contraceptive injection, it was announced at the Family Planning Summit in London on 11 July.
The new contraceptive, depo SubQ Provera 104, was developed by a partnership comprising of the UK Department for International Development (DFID), US aid agency USAID, the Bill & Melinda Gates Foundation, international health NGO PATH and pharmaceutical company Pfizer. Read the whole story here.
Article published in Science & Development Network on 17 July 2012.
Photo courtesy of Russell Watkins/Department for International Development